17 November 2023
17 November 2023
Jayasree Iyer, CEO of Access to Medicine Foundation, discusses that while the pharmaceutical industry is more inclusive, more efforts are needed for global health equity reach.
The year-long study by the Dutch medtech showed 0% infections with the aXess biodegradable haemodialysis access graft.
The mRNA therapy may help to accelerate the regeneration of the urinary sphincter muscle, treating women with stress urinary incontinence.
The Tigerlily Foundation has released a clinical trial best practice framework aimed at encouraging racial diversity in patient enrolment.
The trial will evaluate the safety and efficacy of a once-daily dose of LHP588 to treat P. gingivalis-positive Alzheimer’s.
In the trial, KarXT was found to be well tolerated with a side effect profile similar to trials in the EMERGENT programme.
Clinical Trials Arena explores how post-marketing studies are still led by academia while commercial sponsors spearhead early clinical research.
The US FDA granted fast track designation for ALE.C04 to treat CLDN1+ HNSCC.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
